+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bayer AG - Company Overview and Analysis, 2023 Update

  • PDF Icon

    Company Profile

  • 15 Pages
  • August 2023
  • GlobalData
  • Bayer AG
  • ID: 5894293

Summary

Bayer AG (Bayer) is a German multinational pharmaceutical and biotechnology company that discovers, develops, manufactures, and commercializes a wide range of human health and agriculture products. The company manufactures and markets consumer health, pet care, cosmetics & toiletries (C&T), household, and baby care products. Most of the company’s sales come from the consumer health industry (96.4%). Bayer operates its business across all regions worldwide. Its major business is concentrated in North America, which accounted for 43.9% of value sales in 2022.

Scope

  • North America is the leading revenue generating region for Bayer
  • The consumer health industry is set to grow the fastest in North America
  • West Europe and Asia to present growth prospects for Bayer through 2027
  • Sentiment score sees a declining trend after November 2022

Reasons to Buy

  • Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
  • Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
  • Access valuable strategic take-outs to help direct future decision-making and inform new product development.

Table of Contents

  • Company snapshot
  • Company overview
  • Sales by region and industry
  • Sector forecast overview by region
  • Sales performance outlook
  • News and deals
  • Recruitment trends
  • Social media trends
  • Key themes
  • Appendix

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG